Multiply Labs · May 2026
Launched Multiply Labs Italia and named Enrico Racca as founding general manager to scale manufacturing for robotic clusters.
Robotic production capacity for the pharma manufacturing industry
Public company, workplace, funding, and market signals
Updated Aug 16, 2026
Multiply Labs develops cloud-controlled robotic systems that automate manufacturing of individualized and advanced therapies, especially cell therapy and other biomanufacturing workflows, for pharmaceutical and biotech customers.
Primary product
Robotic biomanufacturing systems for cell and gene therapy manufacturing (advanced therapy automation platform)
Headquarters
San Francisco, California, United States
Team size
60-70
Industry
Robotics Engineering
Sub-industry
Biomanufacturing automation / cell and gene therapy manufacturing robotics
Offices
Business model
Stage
Series A
Total raised
$22.8M
Latest round
Series A · Apr 2021
Latest amount
$20M
Sep 2024
Apr 2021 · Casdin Capital
Seed Round
Dec 2016
Corporate Round
Jan 2016
Leadership
Co-Founder and CEO
Alice Melocchi
CSO
Kevin Liu
VP, Head of Business Operations & People
Lisa Gonzalez
Head of Product
David Hallock
Head of Hardware
Nadia K.
Head of Robotics Software
Angela Lares
Senior Staff Scientist, Head of Bioprocess
Raquel Martin Ibanez
Strategic Alliance Director
Interim Chief of Staff
General Manager ML Italia & Chief of Supply Chain and Manufacturing ML Inc
Founders
Joe Wilson
Public materials emphasize mission-driven robotics and science, rapid experimentation, and a team of roboticists, engineers, and scientists focused on making personalized therapies scalable.
Compensation
No public compensation bands were found in primary sources. Open roles suggest an active hiring posture, but pay signals are not disclosed publicly.
Pricing
Enterprise B2B contracts, pilots, partnerships, and supply agreements; exact pricing not publicly disclosed.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Multiply Labs · May 2026
Launched Multiply Labs Italia and named Enrico Racca as founding general manager to scale manufacturing for robotic clusters.
Multiply Labs newsroom · May 2026
Company launched an Italian manufacturing subsidiary and appointed Enrico Racca to lead it.
Business Wire · Jan 2026
Announced an agreement with AstraZeneca to evaluate GMP-ready robotic systems for commercial-scale cell therapy manufacturing.
Business Wire · Jan 2026
Announced use of NVIDIA Isaac, GR00T, and perception tooling to accelerate biomanufacturing robotics.
Multiply Labs · Sep 2025
Expanded partnership to automate Thermo Fisher's DynaCellect magnetic separation workflow and extend cell-therapy automation.
6 jobs at Multiply Labs